818295

Padagis US LLC — FEI 2127022

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 6, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Minneapolis, MN (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)